Danville, PANCT07028398Now EnrollingIRB Ready

Behavioral Intervention Clinical Trial in Danville, PA

Access cutting-edge behavioral intervention treatment through this clinical trial at a research site in Danville. Study-provided care at no cost to qualified participants.

Sponsored by Geisinger Clinic

Quick Self-Assessment

See if you qualify for this Danville location

Preparing your pre-screening questions…

Expert Care in Danville

Access behavioral intervention specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related behavioral intervention treatment provided free

Apply for This Danville Location

Check if you qualify for this behavioral intervention clinical trial in Danville, PA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Danville

    Convenient for PA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Danville site if eligible
  4. 4Begin participation

About This Behavioral Intervention Study in Danville

The project aims to evaluate a nurse-led intervention to reduce inappropriate emergency department (ED) use among adult patients seen at Geisinger's Community Medicine Service Line (CMSL) clinics. The intervention occurs immediately following an appointment where a patient receives a diagnosis of an ambulatory sensitive condition (ASC; i.e., a condition considered to be a risk factor for near-term ED use). The evaluation will compare eligible patients with an ASC who were randomly assigned to receive follow-up outreach (patient portal message and/or call) from a nurse (who was automatically prompted via the Epic electronic health record system to initiate outreach) with those who were randomly assigned to receive standard care. Analyses will be intent-to-treat. The primary outcome is ED use in the week (i.e., 7 days) following the appointment. We ran an earlier version of this intervention (NCT06798389). The current study is modified based on results and clinical guidance. Specifically, more conditions will be included as qualifying ASCs for enrollment. Patients under 30 will be excluded. And rather than calling all patients as in the original study, patient portal users may be contacted via the portal instead of or in addition to a phone call. Finally, in the first study, the intervention was differentially effective by age group (\<45, 45-64, 65+). Our primary analysis will be conducted separately by age group, though we will also conduct an analysis combining across age groups. We will run the study until we reach at least 4,330 patients in each of the following age groups: patients aged 30-45, patients aged 45-64, patients aged 65+. Therefore, our estimated sample size is at least 4,330x3 = 12,990. We may be required to do an interim data pull and/or stop the study early at the direction of clinical or operational leaders.

Sponsor: Geisinger Clinic

Who Can Participate

Inclusion Criteria

Age 30 years +
Has a qualifying visit in CMSL with an ambulatory sensitive condition (ASC) encounter diagnosis

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Danville?

Yes, this clinical trial (NCT07028398) has an active research site in Danville, PA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Behavioral Intervention Treatment Options in Danville, PA

If you're searching for behavioral intervention treatment options in Danville, PA, this clinical trial (NCT07028398) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Danville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced behavioral intervention specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all behavioral intervention clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in Danville, PA

See all rheumatoid arthritis clinical trials recruiting in Danville — not just this study.

Browse Rheumatoid Arthritis Trials in Danville

Browse More Trials by Condition

Ready to Join in Danville?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Danville, PA